KLCM
CVS icon

KG&L Capital Management’s CVS Health CVS Stock Holding History

KG&L Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,587
Closed -$350K – 185
2024
Q1 		$350K Hold
4,587
– – 0.14% 138
2023
Q4 		$348K Sell
4,587
-24
-0.5% -$1.71K 0.15% 130
2023
Q3 		$317K Sell
4,611
-452
-9% -$32K 0.15% 114
2023
Q2 		$350K Buy
5,063
+496
+11% +$35.3K 0.17% 105
2023
Q1 		$339K Sell
4,567
-47
-1% -$3.94K 0.18% 96
2022
Q4 		$430K Buy
4,614
+9
+0.2% +$868 0.25% 79
2022
Q3 		$439K Sell
4,605
-40
-0.9% -$3.96K 0.25% 78
2022
Q2 		$430K Sell
4,645
-892
-16% -$87.1K 0.23% 84
2022
Q1 		$560K Sell
5,537
-278
-5% -$29.2K 0.23% 86
2021
Q4 		$600K Buy
5,815
+1,544
+36% +$143K 0.24% 86
2021
Q3 		$362K Buy
4,271
+176
+4% +$14.7K 0.16% 107
2021
Q2 		$342K Sell
4,095
-131
-3% -$10.7K 0.16% 108
2021
Q1 		$318K Sell
4,226
-29
-0.7% -$2.11K 0.16% 104
2020
Q4 		$290K Sell
4,255
-1,820
-30% -$118K 0.16% 107
2020
Q3 		$354K Buy
6,075
+2,615
+76% +$163K 0.22% 83
2020
Q2 		$224K Hold
3,460
– – 0.17% 88
2020
Q1 		$205K Sell
3,460
-327
-9% -$21.8K 0.2% 82
2019
Q4 		$281K Sell
3,787
-846
-18% -$59.4K 0.24% 84
2019
Q3 		$292K Sell
4,633
-1,509
-25% -$89.4K 0.26% 72
2019
Q2 		$334K Sell
6,142
-1,901
-24% -$102K 0.32% 70
2019
Q1 		$433K Buy
8,043
+4,189
+109% +$259K 0.44% 59
2018
Q4 		$257K Buy
+3,854
New +$288K 0.29% 77

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

KG&L Capital Management's CVS Position: Q2 2024 in Review

KG&L Capital Management sold out of CVS Health (CVS) in Q2 2024, closing a stake of 4,587 shares — an estimated $350K sold.

KG&L Capital Management first reported a position in CVS in Q4 2018 and held it in 22 quarters. The position peaked at $600K in Q4 2021. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • KG&L Capital Management reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • KG&L Capital Management sold 4,587 CVS Health shares in Q2 2024, an estimated $350K.
  • KG&L Capital Management first reported a position in CVS Health in Q4 2018 and held it in 22 quarters.
  • KG&L Capital Management's CVS Health position peaked at $600K in Q4 2021.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on KG&L Capital Management's 13F filing for Q2 2024, filed 23 Jul 2024.